Jiangsu Simcere Pharmaceutical Co., Ltd.

This study tested whether adding the drug BD0801 to chemotherapy helps people with ovarian cancer that no longer responds to platinum-based treatments. The trial included 421 women with recurrent, platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. The goal …

This early-stage study tested a new drug, SIM0278, in 60 healthy Chinese adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single shot or multiple shots. The main goal was to check for side effects, not to treat any…